跳至主要内容
临床试验/EUCTR2009-011360-10-SE
EUCTR2009-011360-10-SE进行中(未招募)不适用

Effects of ivabradine in patients with stable coronary artery disease without clinical heart failure. A randomised double-blind placebo-controlled international multicentre study. - SIGNIFY

Institut de Recherches Internationales Servier0 个研究点目标入组 16,850 人开始时间: 2009年9月28日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
16,850

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Aged 55 years or older,
  • - Male or female,
  • - Patients with stable coronary artery disease without clinical heart failure,
  • - Sinus rhythm and resting heart rate equal or higher than 70 bpm.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 8900
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 7950

排除标准

  • - Unstable cardiovascular condition,
  • - Contra-indications to the administration of ivabradine or current treatment with marketed ivabradine.

研究者

相似试验

Effects of ivabradine in patients with stable... | 临床试验